Postnatal development of peptidergic innervation of the canine heart

Journal of Molecular and Cellular Cardiology

Volumn 31, Issue 1, 1999, Pages 215-225

  Kralios, Fany A ^a,b,d   Cluff, Nanet ^b   Anderson, Fred L ^b   Hanson, Glen R ^b   Kralios, Alexandros C ^b,c  

^a Training Institute   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF UTAH   (United States)

Author keywords

Arrhythmias; Electrophysiology; Fibrillation; SIDS

Indexed keywords

NEUROPEPTIDE Y; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL TISSUE; ARTICLE; AUTONOMIC INNERVATION; CONTROLLED STUDY; CORONARY ARTERY; DOG; FEMALE; HEART ATRIUM; HEART INNERVATION; HEART MUSCLE; HEART VENTRICLE; MALE; NEWBORN PERIOD; NONHUMAN; PEPTIDERGIC NERVOUS SYSTEM; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; RADIOIMMUNOASSAY;

EID: 0032988631     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1998.0861     Document Type: Article

References (47)

1. Allen JM, Gjorstrup P, Bjorkman A, Ek L, Abrahamsson T, Bloom SR. 1986. Studies on cardiac distribution and function of neuropeptide Y. Acta Physiol Scand 126: 405-411.
2. Anderson FL, Kralios AC, Hershberger R, Bristow MR. 1988. Effects of vasoactive intestinal peptide on myocardial contractility and coronary blood flow in the dog: Comparison to isoproterenol and forskolin. J Cardiovasc Pharmacol 12: 365-371.
3. Anderson FL, Wynn JR, Kimball J, Hanson GR, Hammond E, Hershberger R, Kralios AC. 1992. Vasoactive intestinal peptide in the canine heart. Effect of total cardiac denervation. Am J Physiol 262 (Heart Circ Physiol 31): H598-H602.
4. Anderson FL, Hanson GL, Reid B, Thorpe M, Kralios AC. 1993. VIP and NPY in canine hearts. Distribution and effect of total and selective parasympathetic denervation. Am J Physiol 265 (Heart Circ Physiol 34): H91-H95.
5. Angelakos ET. 1965. Regional distribution of catecholamines in the dog heart. Circ Res 16: 39-44.
6. Bugne R, Johnson M, Ross CD. 1978. Nature and nurture in development of the autonomic neuron. Science 199: 1409-1416.
7. Brum JM, Bove A, Sufan Q, Reilly W, Go WLW. 1986. Action and localization of vasoactive intestinal peptide in the coronary circulation: Evidence for non-adrenergic, non cholinergic coronary regulaton. J Am Coll Cardiol 7: 406-413.
8. Dalsgaard CJ, Franco-Cereceda A, Saria A, Lundberg J, Theodorsson-Norheim E, Hokfelt T. 1986. Distribution and origin of substance P- and neuropeptide Y-immunoreactive nerves in the guinea pig heart. Cell Tissue Res 243: 477-485.
9. Dae MW, Lee RJ, Ursell PC, Chin MC, Stillson CA, Moise NS. 1997. Heterogenous sympathetic innervation in German shepherd dogs with inherited ventricular arrhythmia and sudden death. Circulation 96: 1337-1342.
10. Forssmann WG, Triepel J, Daffner C, Heym CH, Cuevas P, Nobel MM, Yanaihara N. 1988. Vasoactive intestinal peptide in the heart. Vasoactive intestinal peptide and related peptides. Ann NY Acad Sci 527: 405-420.
11. Friedman WF, Pool PE, Jacobwitz D, Seagren SG, Braunwald E. 1968. Sympathetic innervation of the developing rabbit heart. Circ Res 23: 25-32.
12. Geis WP, Tatooles GJ, Priola DV, Friedman WF. 1975. Factors influencing the neurohumoral control of the heart in the newborn dog. Am J Physiol 228: 1685-1689.
13. Gordon L, Polak JM, Moscoso GJ, Smith A, Kuhn DM, Wharton J. 1993. Development of peptidergic innervation of human heart. J Anat 183: 131-140.
14. Gu J, Polack M, Allen JM, Huang WM, Sheppard MN, Tatemoto K, Bloom SR. 1984. High concentrations of a novel peptide, neuropeptide Y, in the innervation of mouse and rat heart. J Histochem Cytochem 32: 467-472.
15. Haass M, Cheng B, Richardt G, Shomig A. 1989. Characterization and presynaptic modulation of stimulation-evoked exocytotic co-release of noradrenaline and neuropeptide Y in the guinea pig heart. Arch Pharmacol 339: 71-78.
16. Hanson GR, Lovenberg W. 1980. Elevation of substance P-like immunoreactivity in the rat central nervous system by protease inhibitors. J Neurochem 35: 1370-1374.
17. Hassall CJ, Burnstock G. 1986. Intrinsic neurons and associated cells of the guinea pig heart in culture. Brain Res 364: 102-113.
18. Hassal CJ, Loesh A, Maynard KI, Burnstock G. 1992. Calcitonin gene-related peptide- and neuropeptide Y-like immunoreactivity in endothelial cells after long term stimulation of perivascular nerves. Neuroscience 48: 723-726.
19. Hendry IA, Campbell J. 1976. Morphometric analysis of rat superior cervical ganglion after axotomy and nerve growth factor treatment. J Neurocytology 5: 351-360.
20. Hirsch EF. 1970. Embryologic and Fetal Development of Cardiac Innervation in the Human Heart. Charles C. Thomas: Springfield, pp 133.
21. Hurn B, Chantler CS. 1970. Production of reagent antibodies. Methods Enzymol 70: 104-142.
22. Kralios AC, Anderson FL, Kralios FA. 1990. Myocardial electrophysiological effects of vasoactive intestinal peptide in dogs. Am J Physiol 259 (Heart Circ Physiol 28): H1559-H1565.
23. Kralios FA, Martin L, Burgess, Millar CK. 1975. Local, ventricular repolarization changes due to sympathetic nerve-branch stimulation. Am J Physiol 228: 1621-1626.
24. Kralios FA, Millar CK. 1978. Functional development of cardiac sympathetic nerves in newborn dogs: Evidence for asymmetrical development. Cardiovasc Res 12: 547-554.
25. Kralios FA, Millar CK. 1981. Sympathetic neural effects on regional atrial recovery properties and cardiac rhythm. Am J Physiol 240 (Heart Circ Physiol 9): H590-H596.
26. Kralios FA, Millar CK. 1985. Changes in ventricular fibrillation threshold with stimulation of cardiac sympathetic nerves of the developing dog. J Develop Physiol 7: 167-176.
27. Kralios FA, Millar CK, Kralios AC. 1992. Developmental changes of ventricular fibrillation threshold and spontaneous defibrillation in young dogs. J Develop Physiol 17: 163-167.
28. Kralios FA, Millar CK, Kralios AC. 1993. Role of heart mass in the developmental changes of ventricular fibrillation threshold and spontaneous defibrillation in young dogs. J Develop Physiol 19: 119-124.
29. Kralios FA, Anderson FL, Hanson GR, Kralios AC. 1995. Myocardial electrophysiological effects of neuropeptide Y in dogs. Am J Physiol 268 (Heart Circ Physiol 37): H2195-H2201.
30. Kralios FA, Kralios AC. 1996. Ventricular fibrillation in the neonate: Elusive or illusive? Reprod Fertil Dev 8: 49-60.
31. Kuisma M, Suominen P, Korpela R. 1995. Pediatric out-of-hospital cardiac arrests: Epidemiology and outcome. Resuscitation 30: 141-150.
32. Lobowitz EA, Novick JS, Rudolf AM. 1972. Development of myocardial sympathetic innervation in the fetal lamb. Ped Res 6: 887-893.
33. Letter AA, Merchant K, Gibb JW, Hanson GR. 1987. Effect of methamphetamine on neurotensin concentrations in rat brain regions. J Pharmacol Exp Ther 241: 443-447.
34. Mas MS, Adams DJ, Gelband H. 1990. Synergistic hypotensive effect of vasoactive intestinal polypeptide and a- blockade with phentolamine. Evidence for vasoactive intestinal peptide a- adrenoceptor coupling in the cardiovascular system of newborn dogs. Circ Res 67: 986-992.
35. McDermott BJ, Millar BC, Piper HM. 1993. Cardiovascular effects of neuropeptide Y: Receptor interactions and cellular mechanisms. Cardiovasc Res 27: 893-905.
36. Millar BC, Wess T, Piper HM, Weber M, Borchard U, McDermott BJ, Balasubramanian A. 1991. Positive and negative contractile effects of neuropeptide Y on ventricular cardiomyocytes. Am J Physiol 261 (Heart Circ Physiol 30): H1727-H1733.
37. Millar BC, Skuce PJ, McDermott BJ, Shaw C, Piper HM. 1991. NPY-like immunoreactivity in freshly isolated rat cardiomyocytes. Regulatory Peptides 25: 250.
38. Myers AK, Farhat MY, Vaz CA, Keizer HR, Zukowska-Grojec Z. 1998. Release of immunoreactive neuropeptide Y by rat platelets. Biophys Res Commun 155: 118-122.
39. Peterson GC. 1977. A simplification of the protein assay method of Lowry et al. Which is generally more applicable. Anal Biochem 83: 346-356.
40. Pernow J, Lundberg JM, Kaiser L, Hjemdahl P, Theodorsson-Norheim E, Martinsson A, Pernow B. 1986. Plasma neuropeptide Y-like immunoreactivity and catecholamines during various degrees of sympathetic activation in man. Clin Physiol 6: 561-578.
41. Pickoff AS, Wang SN, Stolfi A, Mamage D, Ross-Ascuitto NT, Kydon DW, Ascuitto RJ. 1994. Vasoactive intestinal peptide: Electrophysiologic activity in the newborn heart. Ped Res 35: 244-249.
42. Rios R, Stolfi A, Campbell PH, Pickoff AS. 1996. Postnatal development of the putative neuropeptide-Y-mediated sympathetic-parasympathetic autonomic interaction. Cardiovasc Res 31: 96-103.
43. Schwartz PJ. 1976. Cardiac sympathetic innervation and sudden infant death syndrome. A possible pathogenetic link. Am J Med 60: 167-172.
44. Schwartz PJ, Stramba-Badiale M, Segantini A, Austoni P, Bosi G, Giorgetti R, Grancini F, Marni ED, Perticone F, Rosti D, Salice P. 1998. Prolongation of the QT interval and the sudden infant death syndrome. N Engl J Med 338: 1709-1714.
45. Somes JM. 1991. Ventricular fibrillation in a 2-month old infant: A pediatric case study and review of lessons learned. Journal of Emergency Nursing 17: 215-219.
46. Suess U, Lawrence J, Ko D, Lederis K. 1986. Radioimmunoassays for fish tail uropeptides. I. Development of assay and measurement of immunoreactive urotensin I in castonomus commersoni brain, pituitary and plasma. J Pharmacol Meth 15: 335-346.
47. Weihe E, Reinecke M, Forssmann WG. 1984. Distribution of vasoactive intestinal peptide-like immunoactivity in the mammalian heart: Interrelation with neurotensin and substance P polypeptide-like immunoreactive nerves. Cell Tissue Res 236: 527-540.